Medical Diagnostics & Research
- 647.360
- -4.067-0.62%
Monash IVF Group Ltd (MVF) Gets a Buy From Morgans
Sonic Healthcare Price Target Raised 3.3% to A$32.21/Share by Morgans
Monash IVF Price Target Cut 8% to A$1.46/Share by Wilsons
Bell Potter Keeps Their Buy Rating on Genetic Signatures Ltd. (GSS)
Macquarie Remains a Buy on Monash IVF Group Ltd (MVF)
Jarden Research Adjusts Healius' Price Target to AU$1.22 From AU$1.26, Keeps at Underweight
Ord Minnett Starts Australian Clinical Labs at Buy, Price Target Is AU$3.50
Jarden Adjusts Sonic Healthcare Price Target to AU$26.19 From AU$28.88, Keeps at Neutral
RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target Is AU$1.50
Morgan Stanley Adjusts Healius' Price Target to AU$1 From AU$1.30, Keeps at Underweight
Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight
Morgan Stanley Adjusts Monash IVF Group's Price Target to AU$1.65 From AU$1.45, Keeps at Overweight
Jarden Research Adjusts Sonic Healthcare's Price Target to AU$28.88 From AU$31.20, Keeps at Neutral
Analysts Offer Insights on Healthcare Companies: Integral Diagnostics Ltd. (AU:IDX), Biophytis SA (Stuttgart: DE:6XB) and Merck KGaA (GB:0O14)
Analysts Are Bullish on Top Healthcare Stocks: Monash IVF Group Ltd (AU:MVF), Genetic Signatures Ltd. (AU:GSS)